NCT06253559

Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria

Name: Clinical Trial NCT06253559
Creator: Tishreen University
Keywords: Ovarian Cancer, clinical trial, Syrian

Clinical and Pathological Characteristics of Women With Ovarian Cancers, A National, Retrospective Cross-Sectional Study in Syria During the War

Tishreen University·ClinicalTrials.govCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Ovarian Cancer
Study type: Observational

Sponsor & location

Primary sponsor: Tishreen University
Location: Latakia, Syrian

Timeline & enrollment

Phase: N/A
Start date: Jan 01, 2017
End date: Dec 24, 2023
Enrollment: 531 participants

Primary outcome

age,ovarian cancer grade,histological type of ovarian cancer,sideness of ovarian cancer,Cancer Antigen-125,Treatment,symptoms of ovarian cancer

Summary

the goal of this observational study is to describe ovarian cancer epidemiology and characteristics in Syrian women, especially during the war to do more research in the future about the risk factors of ovarian cancer.

ICD-10 classifications

Malignant neoplasm of ovarySecondary malignant neoplasm of ovaryBenign neoplasm of ovaryOvarian pregnancyOvarian dysfunction

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06253559
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06253559 through Pure Global AI's free database. This phase not specified trial is sponsored by Tishreen University and is currently Completed. The study focuses on Ovarian Cancer. Target enrollment is 531 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.